Plasma proteomics identifies potential drug targets for diabetic polyneuropathy: Evidence from prospective cohorts and genetic analysis.

Lan H, Xu S, Li H, Guo R, Ma D, Feng Z, Wang Y

Open source

DOI
10.1111/dom.70239
Published
2026 Jan
Container
Diabetes, obesity & metabolism
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/dom.70239,
  title = {Plasma proteomics identifies potential drug targets for diabetic polyneuropathy: Evidence from prospective cohorts and genetic analysis.},
  author = {Lan H and Xu S and Li H and Guo R and Ma D and Feng Z and Wang Y},
  year = {2026},
  journal = {Diabetes, obesity \& metabolism},
  doi = {10.1111/dom.70239},
  url = {https://doi.org/10.1111/dom.70239}
}

RIS

TY  - JOUR
TI  - Plasma proteomics identifies potential drug targets for diabetic polyneuropathy: Evidence from prospective cohorts and genetic analysis.
AU  - Lan H
AU  - Xu S
AU  - Li H
AU  - Guo R
AU  - Ma D
AU  - Feng Z
AU  - Wang Y
PY  - 2026
JO  - Diabetes, obesity & metabolism
DO  - 10.1111/dom.70239
UR  - https://doi.org/10.1111/dom.70239
ER  - 

APA

H, L., S, X., H, L., R, G., D, M., Z, F., & Y, W. (2026). Plasma proteomics identifies potential drug targets for diabetic polyneuropathy: Evidence from prospective cohorts and genetic analysis.. Diabetes, obesity & metabolism. https://doi.org/10.1111/dom.70239

Source records